[HTML][HTML] Adverse event profile for immunotherapy agents compared with chemotherapy in solid organ tumors: a systematic review and meta-analysis of randomized …

DE Magee, AE Hird, Z Klaassen, SS Sridhar, RK Nam… - Annals of …, 2020 - Elsevier
Background Immunotherapy agents are an innovative oncological treatment modality and as
a result their use has expanded widely. Understanding the treatment-related adverse events …

A community empowerment approach to the HIV response among sex workers: effectiveness, challenges, and considerations for implementation and scale-up

D Kerrigan, CE Kennedy, R Morgan-Thomas… - The Lancet, 2015 - thelancet.com
A community empowerment-based response to HIV is a process by which sex workers take
collective ownership of programmes to achieve the most effective HIV outcomes and …

The economic burden of racial, ethnic, and educational health inequities in the US

TA LaVeist, EJ Pérez-Stable, P Richard, A Anderson… - Jama, 2023 - jamanetwork.com
Importance Health inequities exist for racial and ethnic minorities and persons with lower
educational attainment due to differential exposure to economic, social, structural, and …

A health opportunity cost threshold for cost-effectiveness analysis in the United States

DJ Vanness, J Lomas, H Ahn - Annals of internal medicine, 2021 - acpjournals.org
Background: Cost-effectiveness analysis is an important tool for informing treatment
coverage and pricing decisions, yet no consensus exists about what threshold for the …

[PDF][PDF] Updating cost-effectiveness—the curious resilience of the $50,000-per-QALY threshold

PJ Neumann, JT Cohen, MC Weinstein - N Engl J Med, 2014 - med.unipmn.it
797 ferred a threshold of $200,000 to $300,000 per QALY on the basis of increases in health
care spending over time and the health gains that have been associated with those …

The case against education: Why the education system is a waste of time and money

B Caplan - 2019 - torrossa.com
When I started writing this book, I knew I'd need to read piles of research but failed to foresee
the enormity of the piles. Education isn't just a major industry; it inspires researchers' …

Short-term costs of preeclampsia to the United States health care system

W Stevens, T Shih, D Incerti, TGN Ton, HC Lee… - American journal of …, 2017 - Elsevier
Background Preeclampsia is a leading cause of maternal morbidity and mortality and
adverse neonatal outcomes. Little is known about the extent of the health and cost burden of …

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo …

AL Cheng, YK Kang, Z Chen, CJ Tsao, S Qin… - The lancet …, 2009 - thelancet.com
Background Most cases of hepatocellular carcinoma occur in the Asia-Pacific region, where
chronic hepatitis B infection is an important aetiological factor. Assessing the efficacy and …

Cost-effectiveness and budget impact of hepatitis C virus treatment with sofosbuvir and ledipasvir in the United States

J Chhatwal, F Kanwal, MS Roberts… - Annals of internal …, 2015 - acpjournals.org
Background: Sofosbuvir and ledipasvir, which have recently been approved for treatment of
chronic hepatitis C virus (HCV) infection, are more efficacious and safer than the old …

Delivering affordable cancer care in high-income countries

R Sullivan, J Peppercorn, K Sikora, J Zalcberg… - The lancet …, 2011 - thelancet.com
The burden of cancer is growing, and the disease is becoming a major economic
expenditure for all developed countries. In 2008, the worldwide cost of cancer due to …